EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Biopharmaceutical Quality Assessment of Multisource Ciprofloxacin 500 mg Tablets Circulating in the Federal Capital Territory, Nigeria

Durojaye Aishat Bisoye, Galadima Isa Hayatu, Omachoko Sunday Odoma, Isaac Johnson Ajeh

The Nigerian Journal of Pharmacy · 01.01.2026 · 60 (1) · 35-43

DOI: 10.51412/psnnjp.2026.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Nigerian Journal of Pharmacy, online erschienen am 01.01.2026. Verfasst von Durojaye Aishat Bisoye und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The quality of ciprofloxacin generics in Nigeria is a concern due to the potential for therapeutic failure and antimicrobial resistance.

Objectives

This study evaluated the pharmaceutical equivalence of nineteen (19) brands of ciprofloxacin, 500 mg tablets marketed within the Federal Capital Territory (FCT), Abuja, Nigeria. The samples were purposively collected from registered retail community pharmacies following WHO guidelines for medicine quality surveillance. Methodology: Methodology involved assessing physicochemical properties, dissolution profiles, similarity factor (f2), dissimilarity factor (f1), dissolution efficiency (DE), and mean dissolution time (MDT).

Results

While all brands met pharmacopeial standards for an immediate-release solid oral dosage form, only one brand met both f1 and f2 similarity requirements. Although most brands achieved DE values > 80 %.

Conclusions

While many generics eventually release their full drug content, they do not do so at a rate similar to the reference brand, which is critical for concentration-dependent antibiotics. Similarity and dissimilarity factors can be useful for regulatory purposes; they may not provide the same level of insight as mean dissolution time and dissolution efficiency.

Zitieren

APA

Bisoye, D. A., Hayatu, G. I., Odoma, O. S., & Ajeh, I. J. (2026). Biopharmaceutical Quality Assessment of Multisource Ciprofloxacin 500 mg Tablets Circulating in the Federal Capital Territory, Nigeria. The Nigerian Journal of Pharmacy, 60(1), 35-43. https://doi.org/10.51412/psnnjp.2026.004

Vancouver

Bisoye DA, Hayatu GI, Odoma OS, Ajeh IJ. Biopharmaceutical Quality Assessment of Multisource Ciprofloxacin 500 mg Tablets Circulating in the Federal Capital Territory, Nigeria. The Nigerian Journal of Pharmacy. 2026;60(1):35-43. doi:10.51412/psnnjp.2026.004

BibTeX
@article{Bisoye2026,
  author = {Bisoye, Durojaye Aishat and Hayatu, Galadima Isa and Odoma, Omachoko Sunday and Ajeh, Isaac Johnson},
  title = {Biopharmaceutical Quality Assessment of Multisource Ciprofloxacin 500 mg Tablets Circulating in the Federal Capital Territory, Nigeria},
  journal = {The Nigerian Journal of Pharmacy},
  year = {2026},
  volume = {60},
  number = {1},
  pages = {35--43},
  doi = {10.51412/psnnjp.2026.004}
}
Kostenlos starten →